Stay updated on Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial
Sign up to get notified when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.

Latest updates to the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page
- CheckyesterdayChange DetectedA site-wide notice about a lapse in government funding was added and the software version updated to v3.4.1; the previous version v3.4.0 was removed.SummaryDifference0.6%

- Check8 days agoChange DetectedAdditions include a glossary option in the header and new QC-related metadata: 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Deletions remove the previous items 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.3%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed.SummaryDifference0.1%

- Check44 days agoChange DetectedFooter now includes 'Revision: v3.3.3'. The 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' references were removed.SummaryDifference0.1%

- Check65 days agoChange DetectedA minor version update was applied: Revision: v3.3.2 was added and Revision: v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page revision is updated to v3.3.1, replacing the previous v3.2.0.SummaryDifference0.1%

Stay in the know with updates to Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Surufatinib Plus Sintilimab in Advanced Solid Tumor Clinical Trial page.